Survey of Over 1,000 Asthma and COPD Patients Conducted in Partnership with AAFA Finds Symptoms are Disruptive to Daily Lives for Majority of Respondents Despite Treatment
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of Inhaler Tales – a national campaign aimed toward raising awareness about the role inhaler misuse may play in inadequate disease control.1
Central to the campaign is an animated inhaler voiced by actress, producer, and entrepreneur Sarah Michelle Gellar, who will share her own experience living with asthma and encourage others to require control of their disease.
“I was diagnosed with asthma once I was a child , so i do know the impact respiratory illness can wear your life,” says Gellar. “I’m proud to hitch forces with Teva to launch this important campaign, and to boost awareness about improper inhaler use and therefore the role of objective inhaler use data in informing dialogue between patients and their physicians.”
Respiratory disease can impact your daily life2 if inadequately controlled, and a standard problem is inhaler misuse.3 consistent with a survey of quite 1,000 asthma and chronic obstructive pulmonary disease (COPD) patients conducted by Teva in partnership with the Asthma and Allergy Foundation of America (AAFA), 40% of asthma and COPD patients feel that their conditions get within the way of their lives because they’re in need of breath.4 an equivalent survey found that the bulk of respondents feel confident that they’re using their inhaler correctly, but a considerable proportion might not be using their inhaler as prescribed.5
“Patients want to urge their asthma and COPD under control6,7 but they’ll not realize that poor adherence or incorrect inhaler technique8 might be contributing to worsening symptoms,” said Sanaz Eftekhari, vice chairman of Research at AAFA. “This survey revealed that only 45 percent of respondents report using their maintenance inhaler exactly as prescribed9, and quite 50% could also be overusing their rescue inhaler10, which can cause exacerbation risk.11,12 This campaign will play a crucial role in raising overall awareness about this issue, and signalize to the importance of open dialogue13 between physicians and their patients.”
As of 2019, the Centers for Disease Control and Prevention reported 20 million adults were suffering from asthma14, and another 16 million struggle with COPD.15 Although these respiratory diseases are common, many patients’ asthma or COPD remains uncontrolled.16,17 a spread of things may cause inadequate disease control18 and patients often don’t realize that they’ll be unintentionally19 contributing to the matter by not using their inhalers correctly.20 While patients could also be experiencing these issues, healthcare professionals might not always get the prospect to review inhaler use and technique with their patients as often as recommended.21 Survey findings revealed that a 3rd of respondents forget what they need to debate once they visit their physician.22
For more information about digital health options23, including smart inhalers24, please visit InhalerTales.com.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to enhance people’s lives for quite a century. We are a worldwide leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people round the world take a Teva medicine a day , and are served by one among the most important and most complex supply chains within the pharmaceutical industry. along side our established presence in generics, we’ve significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.
Source link: https://www.tevapharm.com/